Related Experiment Video

Updated: Jun 18, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Optimal medical therapy during carotid endarterectomy: a personal view

A R Naylor1

  • 1Department of Vascular Surgery at Leicester Royal Infirmary, Leicester, UK. ross.naylor@uhl-tr.nhs.uk

Acta Chirurgica Belgica
|December 1, 2009
PubMed

Insights

Optimal medical therapy for carotid endarterectomy (CEA) patients requires standardized antiplatelet and statin treatments, alongside controlled blood pressure and selective Dextran 40 use. This review outlines evidence-based peri-operative best practices for safe procedures and improved patient outcomes.

Area of Science:

  • Vascular Surgery
  • Cardiology
  • Neurosurgery

Background:

  • Carotid endarterectomy (CEA) requires optimal peri-operative medical management.
  • Current medical therapy protocols for CEA are not standardized across health systems.
  • Evidence-based guidelines are needed to optimize patient care during CEA.

Purpose of the Study:

  • To review and suggest evidence-based peri-operative medical therapies for patients undergoing CEA.
  • To provide guidance on standardizing medical management for CEA procedures.
  • To highlight key areas of medical therapy including antiplatelet, statin, and blood pressure management.

Main Methods:

  • Review of current evidence on peri-operative medical therapy for CEA.
  • Author's personal practice reflecting evidence-based recommendations.
  • Focus on specific therapeutic areas: antiplatelet, statin, blood pressure control, heparin, Dextran 40, and hypertension management.

Main Results:

  • Personalized recommendations for antiplatelet and statin therapy.
  • Guidelines for blood pressure control during and after CEA.
  • Considerations for intra-operative heparin and selective post-operative Dextran 40 use.
  • Strategies for managing post-operative hypertension.

Conclusions:

  • Standardization of peri-operative medical therapy for CEA is crucial.
  • Evidence-based management of antiplatelet, statin, and blood pressure is essential for safe CEA.
  • Targeted Dextran 40 and hypertension management improve post-operative care.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...